Search research articles
Contact Us
Filters
Showing results (311-320 of 385) with videos related to
Page
of 39
Sort By:
Early Intervention in Psychiatry
|
January 18, 2023
Predictors of treatment attrition of cognitive health interventions in first episode psychosis
Christy Au-Yeung, Christopher R Bowie, Tina Montreuil, et al.
British Journal of Haematology
|
December 30, 2014
Rituximab combined with DexaBEAM followed by high dose therapy as salvage therapy in patients with relapsed or refractory B-cell lymphoma: mature results of a phase II multicentre study
Sebastian Kirschey, Thomas Flohr, Hans H Wolf, et al.
Hemasphere
|
March 21, 2024
Chimeric antigen receptor-T cell therapy shows similar efficacy and toxicity in patients with diffuse large B-cell lymphoma aged 70 and older compared to younger patients: A multicenter cohort study
Philipp Berning, Evgenii Shumilov, Markus Maulhardt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 19, 2014
Optimization of rituximab for the treatment of diffuse large B-cell lymphoma (II): extended rituximab exposure time in the SMARTE-R-CHOP-14 trial of the german high-grade non-Hodgkin lymphoma study group
Michael Pfreundschuh, Viola Poeschel, Samira Zeynalova, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 20, 2008
Allogeneic hematopoietic stem-cell transplantation for chronic lymphocytic leukemia with 17p deletion: a retrospective European Group for Blood and Marrow Transplantation analysis
Johannes Schetelig, Anja van Biezen, Ronald Brand, et al.
Blood Advances
|
May 13, 2020
The conditional survival analysis of relapsed DLBCL after autologous transplant: a subgroup analysis of LY.12 and CORAL
Sarit Assouline, Shen Li, Christian Gisselbrecht, et al.
British Journal of Haematology
|
October 10, 2017
Optimization of rituximab for the treatment of DLBCL: increasing the dose for elderly male patients
Michael Pfreundschuh, Niels Murawski, Samira Zeynalova, et al.
Haematologica
|
December 11, 2008
Reduced intensity conditioning allogeneic stem cell transplantation for Hodgkin's lymphoma: identification of prognostic factors predicting outcome
Stephen P Robinson, Anna Sureda, Carmen Canals, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 27, 2010
Dose intensity of chemotherapy in patients with relapsed Hodgkin's lymphoma
Andreas Josting, Horst Müller, Peter Borchmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 25, 2011
Cytarabine dose of 36 g/m² compared with 12 g/m² within first consolidation in acute myeloid leukemia: results of patients enrolled onto the prospective randomized AML96 study
Markus Schaich, Christoph Röllig, Silke Soucek, et al.
Page
of 39
Search research articles
Search
Showing results (311-320 of 385) with videos related to
Sort By:
Page
of 39
Early Intervention in Psychiatry
|
January 18, 2023
Predictors of treatment attrition of cognitive health interventions in first episode psychosis
Christy Au-Yeung, Christopher R Bowie, Tina Montreuil, et al.
British Journal of Haematology
|
December 30, 2014
Rituximab combined with DexaBEAM followed by high dose therapy as salvage therapy in patients with relapsed or refractory B-cell lymphoma: mature results of a phase II multicentre study
Sebastian Kirschey, Thomas Flohr, Hans H Wolf, et al.
Hemasphere
|
March 21, 2024
Chimeric antigen receptor-T cell therapy shows similar efficacy and toxicity in patients with diffuse large B-cell lymphoma aged 70 and older compared to younger patients: A multicenter cohort study
Philipp Berning, Evgenii Shumilov, Markus Maulhardt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 19, 2014
Optimization of rituximab for the treatment of diffuse large B-cell lymphoma (II): extended rituximab exposure time in the SMARTE-R-CHOP-14 trial of the german high-grade non-Hodgkin lymphoma study group
Michael Pfreundschuh, Viola Poeschel, Samira Zeynalova, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 20, 2008
Allogeneic hematopoietic stem-cell transplantation for chronic lymphocytic leukemia with 17p deletion: a retrospective European Group for Blood and Marrow Transplantation analysis
Johannes Schetelig, Anja van Biezen, Ronald Brand, et al.
Blood Advances
|
May 13, 2020
The conditional survival analysis of relapsed DLBCL after autologous transplant: a subgroup analysis of LY.12 and CORAL
Sarit Assouline, Shen Li, Christian Gisselbrecht, et al.
British Journal of Haematology
|
October 10, 2017
Optimization of rituximab for the treatment of DLBCL: increasing the dose for elderly male patients
Michael Pfreundschuh, Niels Murawski, Samira Zeynalova, et al.
Haematologica
|
December 11, 2008
Reduced intensity conditioning allogeneic stem cell transplantation for Hodgkin's lymphoma: identification of prognostic factors predicting outcome
Stephen P Robinson, Anna Sureda, Carmen Canals, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 27, 2010
Dose intensity of chemotherapy in patients with relapsed Hodgkin's lymphoma
Andreas Josting, Horst Müller, Peter Borchmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 25, 2011
Cytarabine dose of 36 g/m² compared with 12 g/m² within first consolidation in acute myeloid leukemia: results of patients enrolled onto the prospective randomized AML96 study
Markus Schaich, Christoph Röllig, Silke Soucek, et al.
Page
of 39